Financial Advocates Investment Management Eli Lilly & CO Transaction History

Financial Advocates Investment Management

$1.78 Billion
Q3 2024

A detailed history of Financial Advocates Investment Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Financial Advocates Investment Management holds 6,710 shares of LLY stock, worth $5.15 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

6,710

Previous 7,001 4.16%

Holding current value

$5.15 Million

Previous $6.34 Million 6.22%

% of portfolio

0.33%

Previous 0.4%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$772.14 - $960.02 $224,692 - $279,365	-291 Reduced 4.16%	6,710 $5.94 Million
Q2 2024 Jul 26, 2024	SELL	$724.87 - $909.04 $490,012 - $614,511	-676 Reduced 8.81%	7,001 $6.34 Million
Q1 2024 May 01, 2024	BUY	$592.2 - $792.28 $563,774 - $754,250	952 Added 14.16%	7,677 $5.97 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $44,641 - $52,626	85 Added 1.28%	6,725 $3.92 Million
Q3 2023 Oct 27, 2023	BUY	$434.7 - $599.3 $609,014 - $839,619	1,401 Added 26.74%	6,640 $3.57 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $60,678 - $81,133	173 Added 3.41%	5,239 $2.46 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $162,770 - $191,165	524 Added 11.54%	5,066 $1.74 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $568,178 - $662,041	-1,767 Reduced 28.01%	4,542 $1.66 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $425,152 - $484,505	-1,434 Reduced 18.52%	6,309 $1.38 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $927,055 - $1.09 Million	3,326 Added 75.3%	7,743 $2.51 Million
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $27,224 - $33,832	-116 Reduced 2.56%	4,417 $1.27 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $6,520 - $8,092	29 Added 0.64%	4,533 $1.25 Million
Q3 2021 Nov 04, 2021	BUY	$221.6 - $272.71 $23,711 - $29,179	107 Added 2.43%	4,504 $1.04 Million
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $34,304 - $44,372	190 Added 4.52%	4,397 $1.01 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $25,305 - $32,758	-154 Reduced 3.53%	4,207 $775,000
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $22,308 - $29,519	171 Added 4.08%	4,361 $736,000
Q3 2020 Nov 04, 2020	SELL	$146.22 - $169.13 $77,935 - $90,146	-533 Reduced 11.29%	4,190 $620,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $818 - $985	6 Added 0.13%	4,723 $775,000
Q1 2020 Apr 29, 2020	SELL	$119.05 - $147.35 $48,572 - $60,118	-408 Reduced 7.96%	4,717 $654,000
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $20,100 - $24,896	188 Added 3.81%	5,125 $673,000
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $15,911 - $17,307	149 Added 3.11%	4,937 $552,000
Q2 2019 Aug 08, 2019	BUY	$110.79 - $129.32 $89,296 - $104,231	806 Added 20.24%	4,788 $530,000
Q1 2019 May 16, 2019	SELL	$111.31 - $131.02 $2,560 - $3,013	-23 Reduced 0.57%	3,982 $517,000
Q4 2018 May 09, 2019	SELL	$105.9 - $118.64 $110,559 - $123,860	-1,044 Reduced 20.68%	4,005 $464,000
Q4 2018 Mar 04, 2019	BUY	$105.9 - $118.64 $110,559 - $123,860	1,044 Added 26.07%	5,049 $521,000
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $158,638 - $177,722	-1,498 Reduced 27.22%	4,005 $463,000
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $51,430 - $64,278	599 Added 12.21%	5,503 $0
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $1,741 - $1,998	23 Added 0.47%	4,904 $421,000
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $16,919 - $19,972	-228 Reduced 4.46%	4,881 $378,000
Q4 2017 Feb 15, 2018	BUY	$81.94 - $87.89 $418,631 - $449,030	5,109	5,109 $432,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advocates Investment Management with notifications on news.

Account

Financial Advocates Investment Management Eli Lilly & CO Transaction History